Peptides & Amino Acids

The KRAS Wild Type Peptide (10-18, GAGGVGKSA) is a peptide corresponding to KRAS (Kirsten rat sarcoma virus) wild-type, amino acids 10-18. KRAS Wild Type Peptide (10-18) can be used as negative control in the stimulation of human KRAS G12D-specific CD8⁺ T cells. 

The KRAS G12D Peptide (10-19, GADGVGKSAL) is a peptide corresponding to KRAS (Kirsten rat sarcoma virus) mutant G12D, amino acids 10-19. The KRAS G12D Peptide (10-19) can be used to stimulate human KRAS G12D-specific CD8⁺ T cells.

The KRAS Wild Type Peptide (10-19, GAGGVGKSAL) is a peptide corresponding to KRAS (Kirsten rat sarcoma virus) wild type, amino acids 10-19. KRAS Wild Type Peptide (10-19) can be used as negative control in the stimulation of human KRAS G12D-specific CD8⁺ T cells.

The MAGE-A4 Peptide (286-294, KVLEHVVRV) is a peptide corresponding to MAGE-A4 (Melanoma-associated antigen 4), amino acids 286-294. The MAGE-A4 peptide is widely used to stimulate human MAGE-A4-specific CD8⁺ T cells or as negative control in the stimulation of human MAGE-A1-specific CD8⁺ T cells.

SNAPtide® Peptide Substrate (o-Abz/Dnp) (U.S. Patent #6,504,006)